BOBULSKY SUSAN (SVP, Diagnostics, clonoSEQ) sold 1.2% of their position (5K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $115.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/20/2026ACC: 0001820885-26-000016
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
-5K
Net shares
Net seller
$115.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5K
Price / share
$23.00
Trade value
$115K
% of position
1.2%
7/16/2026
406.29K→401.29K
Total
Net shares
−5K
Net value
-$115K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/16/2026 | S · Sale | −5K | $23.00 | $115K | 1.2% | 406.29K | 401.29K |
| Total | −5K | -$115K | ||||||
Derivative Transactions0
No derivative transactions reported